title: Question 1: should a child with neurofibromatosis type 1 be screened for central nervous system tumours with neuroimaging?
authors.affiliation: Child and Family Unit, Wortley Beck Health Centre, Leeds, UK.
authors.forename: Caroline
authors.initials: C
authors.lastname: Bodey
authors.affiliation: Child and Family Unit, Wortley Beck Health Centre, Leeds, UK.
authors.forename: Arnab
authors.initials: A
authors.lastname: Seal
mesh_terms: D016543:Central Nervous System Neoplasms / Q000175:diagnosis* / Q000209:etiology; D002675:Child, Preschool; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008403:Mass Screening / Q000379:methods*; D009456:Neurofibromatosis 1 / Q000175:diagnosis*; D059906:Neuroimaging / Q000379:methods*
keywords: Endocrinology; Genetics; Neurodisability; Oncology; Screening